Transaction in Own Shares

By

Regulatory News | 15 May, 2024

Updated : 18:01

RNS Number : 6132O
Centrica PLC
15 May 2024
 

 

Transactions in own shares

 

 

Centrica plc

15 May 2024

 

 

Centrica plc announces that today it purchased (through BNP Paribas Financial Markets S.N.C.) 1,150,000 Centrica plc ordinary shares of14/81 pence each at a price of 143.3373 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's 2023-2024 share repurchase programme, details of which were announced on 10 October 2023, and in accordance with the non-discretionary share repurchase agreement entered into with BNP Paribas Financial Markets S.N.C., as announced on 4 March 2024.

 

Since 10 October 2023, Centrica has purchased 222,603,460 ordinary shares at a cost (excluding dealing and associated costs) of £310,014,353.55.

 

Following the above purchase, Centrica plc holds 565,730,863 ordinary shares in treasury, and has 5,313,515,275 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by BNP Paribas Financial Markets S.N.C. is set out below.

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

BNP Paribas Financial Markets S.N.C.

Intermediary LEI:

6EWKU0FGVX5QQJHFGT48

Currency:

GBP

Aggregated information

Date of purchase:

15 May 2024

Number of ordinary shares purchased:

1,150,000

Highest price paid:

144.3000p

Lowest price paid:

141.2000p

Volume weighted average price paid per share:

143.3373p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by BNP Paribas Financial Markets S.N.C., as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

 

http://www.rns-pdf.londonstockexchange.com/rns/6132O_1-2024-5-15.pdf 

 

END

 

Enquiries:

Investors and Analysts
T: 01753 494900
E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGMKVKMGDZM

Last news